Similar articles

• Menopause management: a cardiovascular risk-based approach.

  Haines CJ, Farrell E. Haines CJ, et al. Climacteric. 2010 Aug;13(4):328-39. doi: 10.3109/13697130903450154. Climacteric. 2010. PMID: 20001565
• The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.

  Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM; Women's Health Initiative. Naftolin F, et al. Fertil Steril. 2004 Jun;81(6):1498-501. doi: 10.1016/j.fertnstert.2004.02.095. Fertil Steril. 2004. PMID: 15193467
• ["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered].

  von Schoultz B. von Schoultz B. Lakartidningen. 2001 Jan 31;98(5):412-6. Lakartidningen. 2001. PMID: 11229081 Review. Swedish. No abstract available.
• Modeling women's health during the menopausal transition: a longitudinal analysis.

  Dennerstein L, Lehert P, Guthrie JR, Burger HG. Dennerstein L, et al. Menopause. 2007 Jan-Feb;14(1):53-62. doi: 10.1097/01.gme.0000229574.67376.ba. Menopause. 2007. PMID: 17023873
• Is menopause an independent cardiovascular risk factor? Evidence from population-based studies.

  Casiglia E, Tikhonoff V, Mormino P, Piccoli A, Pessina AC. Casiglia E, et al. J Hypertens Suppl. 2002 May;20(2):S17-22. J Hypertens Suppl. 2002. PMID: 12183844 Review.